Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Wigen Biomedicine Technology presents new Aurora kinase inhibitors

June 30, 2021

New PRMT5 inhibitors discovered at Lupin

June 29, 2021

Kallyope describes new SSTR5 antagonists

June 29, 2021

Cadila Healthcare discovers NLRP3 inflammasome inhibitors

June 29, 2021

New Raf kinase C inhibitors identified at Medshine Discovery

June 29, 2021

BCN Peptides patents peptides and peptide dimers derived from ADAM 12

June 28, 2021

New HIF-2alpha inhibitors identified at Arcus Biosciences

June 28, 2021

New TLR7/8/9 antagonists identified at Roche

June 28, 2021

Albireo synthesizes new IBAT/LBAT inhibitors

June 28, 2021

Peking University Third Hospital, Chigenovo Co. describe therapies including CYP4V2 and RdCVF

June 28, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.